- Home
- FLC vs SMTI Comparison
FLC vs SMTI Comparison
Compare FLC & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FLC | SMTI |
|---|---|---|
| Founded | 2003 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.0M | 186.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FLC | SMTI |
|---|---|---|
| Price | $17.60 | $21.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $41.00 |
| AVG Volume (30 Days) | 37.8K | ★ 44.1K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 6.64% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $101,877,532.00 |
| Revenue This Year | N/A | $21.60 |
| Revenue Next Year | N/A | $16.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 30.52 |
| 52 Week Low | $12.62 | $18.90 |
| 52 Week High | $15.45 | $38.25 |
Technical Indicators
Market Signals| Indicator | FLC | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 55.38 | 38.29 |
| Support Level | $17.50 | $22.60 |
| Resistance Level | $17.68 | $22.98 |
| Average True Range (ATR) | 0.11 | 1.10 |
| MACD | 0.00 | -0.28 |
| Stochastic Oscillator | 66.67 | 2.64 |
Price Performance
Historical ComparisonAbout FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.